- Home
- SBFM vs IDAI Comparison
SBFM vs IDAI Comparison
Compare SBFM & IDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFM
- IDAI
- Stock Information
- Founded
- SBFM 2006
- IDAI 2016
- Country
- SBFM United States
- IDAI United States
- Employees
- SBFM N/A
- IDAI N/A
- Industry
- SBFM Biotechnology: Pharmaceutical Preparations
- IDAI Computer Software: Prepackaged Software
- Sector
- SBFM Health Care
- IDAI Technology
- Exchange
- SBFM Nasdaq
- IDAI Nasdaq
- Market Cap
- SBFM 3.7M
- IDAI 4.2M
- IPO Year
- SBFM N/A
- IDAI N/A
- Fundamental
- Price
- SBFM $2.35
- IDAI $0.19
- Analyst Decision
- SBFM
- IDAI
- Analyst Count
- SBFM 0
- IDAI 0
- Target Price
- SBFM N/A
- IDAI N/A
- AVG Volume (30 Days)
- SBFM 151.4K
- IDAI 2.6M
- Earning Date
- SBFM 11-05-2024
- IDAI 11-26-2024
- Dividend Yield
- SBFM N/A
- IDAI N/A
- EPS Growth
- SBFM N/A
- IDAI N/A
- EPS
- SBFM N/A
- IDAI N/A
- Revenue
- SBFM $32,959,491.00
- IDAI $2,160,186.00
- Revenue This Year
- SBFM $86.70
- IDAI N/A
- Revenue Next Year
- SBFM $126.76
- IDAI $215.04
- P/E Ratio
- SBFM N/A
- IDAI N/A
- Revenue Growth
- SBFM 61.94
- IDAI 69.90
- 52 Week Low
- SBFM $2.25
- IDAI $0.16
- 52 Week High
- SBFM $638.00
- IDAI $2.50
- Technical
- Relative Strength Index (RSI)
- SBFM 25.54
- IDAI 43.44
- Support Level
- SBFM $2.58
- IDAI $0.16
- Resistance Level
- SBFM $2.86
- IDAI $0.20
- Average True Range (ATR)
- SBFM 0.17
- IDAI 0.03
- MACD
- SBFM -0.04
- IDAI -0.00
- Stochastic Oscillator
- SBFM 12.67
- IDAI 22.48
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. The company is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA targeted for liver cancer, (ii) SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections, and (iii) Adva-27a for pancreatic cancer. The company has two reportable segments: Prescription Generic Pharmaceuticals ("Generic Pharmaceuticals") and Nonprescription Over-The-Counter Products ("OTC Products"). The company generates the majority of its revenue from the Generic Pharmaceuticals segment.
About IDAI T Stamp Inc.
T Stamp Inc develops and markets identity authentication software solutions for enterprise partners and peer-to-peer markets. The company is engaged in developing proprietary artificial intelligence-powered solutions; researching and leveraging biometric science, cryptography, and data mining to deliver insightful identity & trust predictions while identifying and defending against fraudulent identity attacks, protecting sensitive user information, and extending the reach of digital services through accessibility.